Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Jubilant Pharmova Limited (NSE: JUBLPHARMA), ISIN INE700A01033 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
JUBLPHARMA last traded at ₹967.90 (+2.65%), with a 52-week range of ₹786.05 to ₹1162.00 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 47.68%, FIIs 15.37%, DIIs 13.01%, mutual funds 9.42%.
EquiSense Score (ECS): 47/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.